R F A Logan

Author PubWeight™ 35.13‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut 2003 3.30
2 Outcomes following acute nonvariceal upper gastrointestinal bleeding in relation to time to endoscopy: results from a nationwide study. Endoscopy 2012 2.58
3 Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Gut 2004 1.92
4 Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001. Br J Cancer 2006 1.58
5 Antibiotic use and the development of Crohn's disease. Gut 2004 1.56
6 Risk of extra-oesophageal malignancies and colorectal cancer in Barrett's oesophagus and gastro-oesophageal reflux. Scand J Gastroenterol 2004 1.42
7 Interactions between Helicobacter pylori and other risk factors for peptic ulcer bleeding. Aliment Pharmacol Ther 2002 1.35
8 Fracture experience of patients with coeliac disease: a population based survey. Gut 2003 1.30
9 Risk of vascular disease in adults with diagnosed coeliac disease: a population-based study. Aliment Pharmacol Ther 2004 1.22
10 Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based cohort study. Gut 2004 1.17
11 Patient perceptions of the burden of coeliac disease and its treatment in the UK. Aliment Pharmacol Ther 2009 1.16
12 Fertility and pregnancy-related events in women with celiac disease: a population-based cohort study. Gastroenterology 2005 1.11
13 National audit of the use of surgery and radiological embolization after failed endoscopic haemostasis for non-variceal upper gastrointestinal bleeding. Br J Surg 2012 1.08
14 Mortality from acute upper gastrointestinal bleeding in the United kingdom: does it display a "weekend effect"? Am J Gastroenterol 2011 1.06
15 Cigarette smoking and adult coeliac disease. Scand J Gastroenterol 2002 1.01
16 Meta-analysis: Helicobacter pylori'test and treat' compared with empirical acid suppression for managing dyspepsia. Aliment Pharmacol Ther 2008 0.99
17 Autoimmune cholestatic liver disease in people with coeliac disease: a population-based study of their association. Aliment Pharmacol Ther 2005 0.95
18 Outcomes following early red blood cell transfusion in acute upper gastrointestinal bleeding. Aliment Pharmacol Ther 2010 0.94
19 High prevalence of undetected ulcerative colitis: data from the Nottingham fecal occult blood screening trial. Am J Gastroenterol 2002 0.92
20 The long-term risk of malignancy following a diagnosis of coeliac disease or dermatitis herpetiformis: a cohort study. Aliment Pharmacol Ther 2012 0.90
21 Is an internal comparison better than using national data when estimating mortality in longitudinal studies? J Epidemiol Community Health 2006 0.90
22 Genome screening of coeliac disease. J Med Genet 2002 0.87
23 No seasonality in month of birth of inflammatory bowel disease cases: a prospective population based study of British under 20 year olds. Gut 2002 0.84
24 Fracture risk of women with primary biliary cirrhosis: no increase compared with general population controls. Aliment Pharmacol Ther 2004 0.82
25 No increase in risk of fracture, malignancy or mortality in dermatitis herpetiformis: a cohort study. Aliment Pharmacol Ther 2008 0.81
26 Thymidylate synthase polymorphisms, folate and B-vitamin intake, and risk of colorectal adenoma. Br J Cancer 2007 0.80
27 Impact of the two-week referral guideline on time to diagnosis and treatment in oesophago-gastric cancer. Clin Med 2003 0.79
28 Clinical trial: a randomized trial of early endoscopy, Helicobacter pylori testing and empirical therapy for the management of dyspepsia in primary care. Aliment Pharmacol Ther 2008 0.77
29 Variation in the CTLA4/CD28 gene region confers an increased risk of coeliac disease. Ann Hum Genet 2002 0.76
30 The effects of population-based faecal occult blood test screening upon emergency colorectal cancer admissions in Coventry and north Warwickshire. Gut 2008 0.75